CRISPR/Cas12a and aptamer-chemiluminescence based analysis for the relative abundance determination of tumor-related protein positive exosomes for breast cancer diagnosis
Authors:
- 11 May 2024
- journal article
- research article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 259, 116380
Abstract
No abstract availableKeywords
Funding Information
- NSFC (21874082)
- Shenzhen Municipal Fundamental Research Program (JCYJ20200109143014453)
This publication has 39 references indexed in Scilit:
- Asymmetrically split DNAzyme-based colorimetric and electrochemical dual-modal biosensor for detection of breast cancer exosomal surface proteinsBiosensors and Bioelectronics, 2023
- One-step multiplex analysis of breast cancer exosomes using an electrochemical strategy assisted by gold nanoparticlesAnalytica Chimica Acta, 2023
- A dual-modal aptasensor based on a multifunctional acridone derivate for exosomes detectionAnalytica Chimica Acta, 2022
- An all-in-one telomerase assay based on CRISPR-Cas12a trans-cleavage while telomere synthesisAnalytica Chimica Acta, 2021
- Localized fluorescent imaging of multiple proteins on individual extracellular vesicles using rolling circle amplification for cancer diagnosisJournal of Extracellular Vesicles, 2020
- Immunoassay-type biosensor based on magnetic nanoparticle capture and the fluorescence signal formed by horseradish peroxidase catalysis for tumor-related exosome determinationMicrochimica Acta, 2020
- Rapid and sensitive exosome detection with CRISPR/Cas12aAnalytical and Bioanalytical Chemistry, 2020
- Near‐Infrared Afterglow Semiconducting Nano‐Polycomplexes for the Multiplex Differentiation of Cancer ExosomesAngewandte Chemie International Edition, 2019
- Chemiluminescence and immunoassaysJournal of Pharmaceutical and Biomedical Analysis, 1994
- The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigenCancer, 1991